LDL subfractions in patients with myocardial infarction: Effect of smoking and β-blocker treatment

Annals of Clinical Biochemistry

Volumn 37, Issue 3, 2000, Pages 313-318

  Theodoraki, Theodora G ^a,b   Tsoukatos, Demokritos C ^b   Karabina, Sonia Athena ^b   Rallidis, Loukianos S ^a   Papageorgakis, Nikolaos H ^a   Tselepsis, Alexandros D ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; HEART INFARCTION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0034091693     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563001899456     Document Type: Article

References (30)

1. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Heart Study. JAMA 1986; 256: 2835-8
2. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low density lipoprotein in normal humans. J Lipid Res 1982; 23: 97-104
3. Krauss RM. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 1994; 5: 339-49
4. Chapman MJ, Goldstein S, Lagrange D, Laplaud PM. A density gradient ultracentrifugal procedure for isolation of the major lipoprotein classes from human serum. J Lipid Res 1981; 22: 339-58
5. Chapman MJ, Laplaud PM, Luc J, Forgez P, Brucker E, Goulinet S, et at. Further resolution of the low density lipoprotein spectrum in normal human plasma: physicochemical characteristics of discrete subspecies separated by density gradient ultracentrifugation. J Lipid Res 1988; 29: 442-58.
6. Austin MA, Breslow JL, Hennekens CH, Buring JE, Wilett WC, Krauss RM. Low density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988; 260: 1917-21
7. Griffin BA, Freeman DI, Tait GW, Thomson J, Caslake MJ, Packard CJ, et al. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small dense LDL coronary heart disease risk. Atherosclerosis 1994; 106: 241-53
8. Campos H, Genest JJ, Blijlevens E, McNamara JR, Jenner JL, Ordovas JM, et al. Low density lipoprotein particle size and coronary artery disease. Arterioscler Thromb 1992; 12: 187-95
9. Coresh J, Kwiterovich PO, Smith HH, Bachorik PS. Association of plasma triglyceride concentration and LDL particle diameter, density and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993; 34: 1687-97
10. Rajman I, Kendall MJ, Cramb R, Holder RL, Salih M, Gammage MD. Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996; 125: 231-42
11. Austin MA, Hokanson JE, Brunzell JD. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 395-403
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
13. de Graaf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298-306
14. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75
15. Tornvall P. Karpe F, Carlson LA, Hamsten A. Relationship of low density lipoprotein subfractions to angiographically defined coronary artery disease in young survivors of myocardial infarction. Atherosclerosis 1991; 90: 67-80
16. Swinkels DW, Demacker PNM, Hendriks JCM, Van't Laar A. Low density lipoprotein subfractions and relationship to other risk factors for coronary artery disease in healthy individuals. Arteriosclerosis 1989; 9: 604-13
17. Dejager S, Brucket E, Chapman MJ. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 1993; 34: 295-308
18. Tribble DL, Krauss RM, Lansberg MG, Thiel PM, van den Berg JJM. Greater oxidative susceptibility of the surface monolayer in small dense LDL may contribute to differences in copper-induced odixation among LDL density subfractions. J Lipid Res 1995; 36: 662-71
19. Nigon F, Lesnik P, Rouis M, Chapman MJ. Discrete subspecies of human low-density lipoproteins are heterogeneous in their interaction with the LDL receptor. J Lipid Res 1991; 32: 1741-54
20. Galeano NF, Milne R, Marcel YL, Walsh MT, Levy E, Nguyen TD, et al. Apolipoprotein-B structure and receptor recognition of triglyceride-rich low-density lipoprotein (LDL) is modified in small LDL but not in triglyceride-rich LDL of normal size. J Biol Chem 1994; 269: 511-19
21. Chen GC, Liu W, Duchateau P, Allaart J, Hamilton RL, Mendel CM, et al. Conformational differences in human apolipoprotein B-100 among subspecies of low density Iipoproteins (LDL). Association of altered proteolytic accessibility with decreased receptor binding of LDL subspecies from hypertriglyceridaemic subjects. J Biol Chem 1994; 269: 29121-8
22. Nordestgaard BG, Nielsen LB. Atherosclerosis and arterial influx of lipoproteins. Curr Opin Lipidol 1994; 4: 252-7
23. Camejo G, Hurt-Camejo E, Olsson U, Bondjers G. Proteoglycans and lipoproteins. Curr Opin Lipidol 1993 3: 77-92
24. Steinberg D, Pathasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increase atherogenicity. N Engl J Med 1989; 320: 915-24
25. Superko HR, Haskell WL, Krauss RM. Association of lipoprotein subclass distribution with the use of selective and non-selective beta-blocker medications in patients with coronary heart disease. Atherosclerosis 1993; 101: 1-8
26. Caslake MJ, Packard CJ, Series JJ, Yip B, Dagen MM, Shepherd J. Plasma triglyceride and low density lipoprotein metabolism. Eur Clin J Invest 1992; 22: 96-104
27. Freeman DJ, Griffin BA, Murray E, Lindsay GM, Gaffney D, Packard CJ, et al. Smoking and plasma lipoproteins: effects on low density lipoprotein cholesterol levels and high density lipoprotein subfraction distribution. Eur J Clin Invest 1993; 23: 630-40
28. Austin MA, Krauss RM. Genetic control of low-density lipoprotein subclasses. Lancet 1986; ii: 592-7
29. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990; 82: 495-506
30. Austin MA. Genetic epidemiology of low-density lipoprotein subclass phenotypes. Ann Med 1992; 24: 477-81